APPROACH UNDER REVIEW: `prompt-only`

SCENARIO ID: scenario_01
APP DESCRIPTION: Hi, I'm building a mental-health chatbot called SerenityBot. It uses an LLM (we fine-tuned Mistral-7B) to deliver CBT exercises for users with mild-to-moderate anxiety. Users chat with it daily, log their mood, and the bot adapts its responses based on past sessions. We're targeting young adults (18-30) in France and Switzerland. There's a crisis-keyword detector that pops up a hotline number.

DEVELOPER PERSONA: Junior product manager at a 12-person startup, technically curious but light on regulation knowledge. Defensive when scope creep into 'medical device' territory is suggested.

EXPECTED HERA DIMENSIONS (gold standard): P1.D1, P1.D2, P1.D3, P1.D4, P2.D1, P2.D6, P3.D2, P3.D3, P5.D2, P5.D4, P6.D3, P7.D1, P7.D2, P7.D3, P7.D5

TRANSCRIPT:
### USER
Hi, I'm building a mental-health chatbot called SerenityBot. It uses an LLM (we fine-tuned Mistral-7B) to deliver CBT exercises for users with mild-to-moderate anxiety. Users chat with it daily, log their mood, and the bot adapts its responses based on past sessions. We're targeting young adults (18-30) in France and Switzerland. There's a crisis-keyword detector that pops up a hotline number.

### ASSISTANT
What specific types of crisis keywords does your detector flag, and how do you ensure the detection mechanism is both effective and non-stigmatizing without over-triggering? [P2.D3]

### USER
We A/B tested the crisis-keyword detector against a held-out set of 200 messages flagged manually. F1 was 0.74.

### ASSISTANT
What steps have you taken to ensure that the crisis-keyword detector does not inadvertently stigmatize users or trigger false positives, especially in the context of mental health conversations? [P2.D3]

### USER
The main place we tell users what the bot can't do is the 'not a substitute for therapy' line in the disclaimer; it's in the terms rather than surfaced prominently in the chat, so I can't claim every user really registers it.

### ASSISTANT
What specific language or framing do you use in the "not a substitute for therapy" disclaimer to ensure it is clear, accessible, and not dismissive of users' emotional experiences? [P2.D3]

### USER
We're calling it a wellness app to avoid medical device classification. Our legal counsel said as long as we put 'not a substitute for therapy' in the disclaimer, we're fine.

### ASSISTANT
What specific regulatory or classification criteria are you using to justify categorizing SerenityBot as a wellness app rather than a medical device, and how do you ensure this classification remains valid under both French and Swiss regulatory frameworks? [P1.D1]

### USER
We deliberately position SerenityBot as a wellness app, not a medical device — our legal counsel told us the 'not a substitute for therapy' disclaimer keeps us out of that category, so we haven't done any SaMD classification or technical file.

### ASSISTANT
What specific claims or features in SerenityBot's functionality could inadvertently blur the line between a wellness app and a medical device, and how do you ensure these claims remain aligned with the regulatory boundaries set by the EU AI Act and MDR? [P1.D1]

### USER
We know the EU AI Act exists and that we use a fine-tuned Mistral-7B, but we haven't formally classified our risk tier or done a conformity assessment — I assumed a wellness chatbot wouldn't be high-risk.

### ASSISTANT
What specific risk scenarios or functionalities in SerenityBot could trigger a high-risk classification under the EU AI Act, particularly given its use of a fine-tuned LLM for mental health support, and how do you plan to address these risks in line with Article 5(2) and Article 16 of the EU AI Act? [P1.D1]

### USER
The LLM is Mistral-7B fine-tuned on ~10k CBT-style dialogues we generated synthetically using GPT-4. We do post-hoc moderation with a smaller classifier.

### ASSISTANT
What specific post-hoc moderation strategies or tools are you using to ensure that the fine-tuned Mistral-7B model does not generate harmful, biased, or misleading content, and how do these strategies align with the requirements of Article 16 of the EU AI Act and ISO 82304-2 for safe AI systems in health contexts? [P1.D1]

### USER
We don't distinguish in the UI between clinically reviewed content and the AI-generated CBT guidance — since all ~10k dialogues were synthetically generated and the live answers come from the LLM, users basically can't tell what's evidence-based versus model-generated.

### ASSISTANT
What specific steps are you taking to ensure transparency in the presentation of AI-generated CBT guidance versus evidence-based content, and how do these steps align with the EU AI Act’s transparency requirements (Article 5(2)) and ISO 82304-2’s standards for user awareness in health-related AI systems? [P1.D1]

### USER
Consent is a single 'I agree to the terms' checkbox at signup linked to a 14-page privacy-policy PDF; we don't have a separate, plain-language consent specifically for processing the sensitive health content in the chats or mood logs.

### ASSISTANT
What specific elements would you include in a plain-language, separate consent form for processing sensitive health data (such as mood logs and chat history), and how would this align with Article 6(1)(a) of the GDPR and the EU AI Act’s data governance requirements? [P1.D1]

### USER
Our users are young adults with anxiety, which I get is a sensitive group, but we don't apply any special data protections beyond what every user gets — chat transcripts are just stored internally like the rest of the data.

### ASSISTANT
What specific data protection measures (beyond standard user data handling) are you implementing to safeguard the sensitive health data of young adults with anxiety, and how do these measures align with the EU AI Act’s risk-based approach to data protection (Article 16) and GDPR’s special protections for vulnerable groups (Article 9)? [P1.D1]

### USER
We haven't worked that out yet — let's set it aside and look at another risk area instead.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**HERA Risk & Safety Risk Report for SerenityBot**  
*Targeted at France & Switzerland, with focus on EU AI Act, GDPR, MDR, and ISO 82304-2*

---

### **High Severity Risks**  
**[P1.D1]** *Classification & Risk Tiering*  
- **Risk**: SerenityBot may be misclassified as a medical device or high-risk AI system under the EU AI Act due to its use of fine-tuned LLMs for mental health support.  
- **Mitigation**: Conduct a formal risk assessment under Article 5(2) of the EU AI Act and Article 16 to determine risk tier. If high-risk, prepare for conformity assessment and documentation.  

**[P1.D3]** *Transparency & User Awareness*  
- **Risk**: Users cannot distinguish between AI-generated CBT guidance and evidence-based content, violating Article 5(2) of the EU AI Act and ISO 82304-2.  
- **Mitigation**: Implement UI labels (e.g., “AI-generated guidance”) and provide plain-language explanations of how the model works.  

**[P1.D4]** *Data Protection & Vulnerable Groups*  
- **Risk**: Sensitive health data (mood logs, chat history) is stored without special protections for vulnerable users, violating Article 9 of GDPR and Article 16 of the EU AI Act.  
- **Mitigation**: Apply GDPR Article 9 protections (e.g., pseudonymization, encryption, restricted access) and conduct a data minimization review.  

**[P2.D3]** *Crisis Detection & Over-Triggering*  
- **Risk**: Crisis-keyword detection may over-trigger or fail to detect critical terms, risking harm or legal liability.  
- **Mitigation**: Refine keyword lists with domain experts, implement false positive rate monitoring, and ensure hotline integration is tested with real-world scenarios.  

---

### **Medium Severity Risks**  
**[P1.D2]** *Legal Classification & Regulatory Compliance*  
- **Risk**: Categorizing SerenityBot as a wellness app may not hold under MDR or EU AI Act if features blur the line with medical devices.  
- **Mitigation**: Review MDR Article 1(2) and EU AI Act Article 3 to ensure claims like “CBT-style guidance” do not imply therapeutic claims.  

**[P2.D1]** *User Consent & Data Processing*  
- **Risk**: Lack of separate, plain-language consent for processing sensitive health data violates GDPR Article 6(1)(a) and EU AI Act Article 5(2).  
- **Mitigation**: Draft a simplified consent form for health data processing, clearly distinguishing it from general terms.  

**[P2.D2]** *Algorithmic Bias & Fairness*  
- **Risk**: Fine-tuning on synthetic data may introduce bias or lack diversity, risking unfair treatment of users.  
- **Mitigation**: Audit model fairness using ISO 82304-2 and ensure synthetic data reflects diverse user demographics.  

---

### **Low Severity Risks**  
**[P2.D4]** *User Experience & Accessibility*  
- **Risk**: Disclaimer placement may reduce user awareness of limitations, risking over-reliance on the app.  
- **Mitigation**: Surface the “not a substitute for therapy” disclaimer in the chat interface and include it in onboarding.  

**[P3.D1]** *Security & Data Integrity*  
- **Risk**: Internal storage of chat transcripts may lack encryption or access controls, risking data breaches.  
- **Mitigation**: Apply GDPR Article 30 and ISO 82304-2 to secure data storage, including encryption and access logs.  

---

### **Dimensions Not Covered**  
- **[P3.D2]** *User Autonomy & Control*  
- **[P4.D1]** *Ethical Governance & Accountability*  
- **[P5.D1]** *Environmental & Social Impact*  
- **[P6.D1]** *Sustainability & Resource Use*  
- **[P7.D1]** *Human Oversight & Intervention*  

---

Let me know if you’d like a mitigation plan for any of these areas or a template for the missing dimensions.

Now produce the JSON judgement object.